Mankind Pharma, BDR Pharma partner for COVID drug Baricitinib in India Ruchika Sharma25 Jun 2021 2:00 PM ISTNew Delhi: Mankind Pharma has recently announced that the company has partnered with BDR Pharmaceuticals International Pvt. Ltd for distributing the...
Baricitinib shows promise in treating Alopecia areata,finds study Dr Satabdi Saha22 Jun 2021 9:00 AM ISTRecent research results support the efficacy and safety of baricitinib in patients with more than 50% scalp hair loss. These findings have been put...
Exclude patients with history of TB from Baricitinib clinical study for Atopic Dermatitis: CDSCO panel tells Eli Lilly Medical Dialogues Team15 Jun 2021 4:56 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has asked Eli Lilly to conduct a...
Baricitinib- a long term treatment option for moderate to severe atopic dermatitis Dr. Nandita Mohan4 Jun 2021 8:15 AM ISTAccording to recent research, investigators from the Department of Dermatology, George Washington University School of Medicine, Washington, DC have...
Eli Lilly, BDR Pharma ink pact for COVID drug Baricitinib Ruchika Sharma23 May 2021 9:00 AM ISTNew Delhi: Drug firm BDR Pharma on Wednesday said it has inked a licensing pact with Eli Lilly and Company for the manufacturing and distribution...
Natco Pharma enters agreement with Eli Lilly for COVID drug Baricitinib Ruchika Sharma18 May 2021 11:51 AM ISTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced the signing of a royalty-free, non-exclusive, voluntary licensing agreement with...
Torrent Pharma, Eli Lilly ink pact to boost Baricitinib production in India Ruchika Sharma14 May 2021 3:23 PM ISTAhmedabad: Following in the footsteps of Sun Pharma, Cipla, and Lupin in signing a voluntary licencing agreement with Eli Lilly to accelerate the...
Dr Reddys, Eli Lilly collaborate for manufacturing, commercializing Baricitinib in India Ruchika Sharma13 May 2021 9:15 AM ISTHyderabad: Drug major, Dr. Reddy's Laboratories Ltd., has recently announced that the company has entered into a royalty-free, non-exclusive...
Eli Lilly ink licensing pact with Sun Pharma, Cipla, Lupin to expedite COVID drug Baricitinib Ruchika Sharma10 May 2021 1:55 PM ISTNew Delhi: Drug firm Eli Lilly and Company on Monday said it has inked voluntary licensing agreements with Indian drug firms -- Sun Pharma, Cipla...
Natco Pharma launches Baricitinib in India without patent waiver approval Medical Dialogues Team7 May 2021 3:26 PM ISTNew Delhi: Casting caution to the wind, Natco Pharma has already started distributing its generic version of the rheumatoid arthritis drug Baricitinib...
Combating COVID: Eli Lilly accelerating baricitinib availability in India Ruchika Sharma6 May 2021 12:00 PM ISTIndianapolis: Eli Lilly and Company has recently announced new initiatives to help COVID-19 patients in India as part of its commitment to...
Baricitinib promising in managing alopecia areata; reports phase 3 clinical trial Dr Satabdi Saha7 March 2021 9:24 PM IST In a recent development, results from a phase 3 clinical trial have suggested that baricitinib has demonstrated a statistically significant ...
